Constellation Pharmaceuticals Inc.

06/04/2021 | Press release | Distributed by Public on 06/04/2021 07:10

Poster Presentation of Phase 1/2 First-in-Human (FIH) Study of CPI-0209 in Patients With Advanced Tumors, Presented at ACRO, June 4, 2021